These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4112160)

  • 1. Effects in vivo of -(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on platelet aggregation and blood coagulation.
    MacKenzie RD; Blohm TR; Steinbach JM
    Biochem Pharmacol; 1972 Mar; 21(5):707-17. PubMed ID: 4112160
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of -(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol, an inhibitor of platelet aggregation.
    Claxton GP; Grisar JM; Roberts EM; Fleming RW
    J Med Chem; 1972 May; 15(5):500-4. PubMed ID: 5035270
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of flurbiprofen (2-(2-fluoro-4-biphenylyl) propionic acid) on platelet function and blood coagulation.
    Davies T; Lederer DA; Spencer AA; McNicol GP
    Thromb Res; 1974 Nov; 5(5):667-83. PubMed ID: 4445988
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a new antiaggregating chemical on the structure and function of the human platelet.
    Rodman NF; Mason RG; Brinkhous KM
    Am J Pathol; 1971 Oct; 65(1):103-16. PubMed ID: 4255415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB
    Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time.
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1277-83. PubMed ID: 4801220
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibitory effect of metergoline (an anti-5-hydroxytryptaminic agent) on rabbit platelet aggregation.
    Fregnan GB
    Pharmacology; 1972; 7(2):115-25. PubMed ID: 5054073
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by anti-5-hydroxytryptaminic and alpha-adrenergic blocking agents.
    Fregnan GB
    Acta Univ Carol Med Monogr; 1972; 53():263-8. PubMed ID: 4151573
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet aggregation by drugs.
    Glusa E
    Acta Univ Carol Med Monogr; 1972; 52():83-6. PubMed ID: 4669829
    [No Abstract]   [Full Text] [Related]  

  • 11. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of intravenous ADP on thrombocyte aggregation and blood coagulation in animals].
    Pastorova VE; Timova IP
    Probl Gematol Pereliv Krovi; 1972 Jul; 17(7):32-7. PubMed ID: 4667313
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemostatic abnormalities in heroin addicts.
    Puszkin E; Gutfreund D; Aledort LM
    Transfusion; 1972; 12(1):9-11. PubMed ID: 5009587
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylenic analog of arachidonate that acts like aspirin on platelets.
    Willis AL; Kuhn DC; Weiss HJ
    Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dilazep on platelet aggregation.
    Nakajima K; Shirai K; Takimoto M; Satoh F; Aoki M
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1899-901. PubMed ID: 4480271
    [No Abstract]   [Full Text] [Related]  

  • 17. 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one, a potent inhibitor of ADP-induced platelet aggregation.
    Beverung WN; Partyka RA
    J Med Chem; 1975 Feb; 18(2):224-5. PubMed ID: 1120996
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of manganese on the ADP-induced platelet aggregation.
    Fantin GP; Bottecchia D
    Experientia; 1974 May; 30(5):555-6. PubMed ID: 4833692
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregation.
    Tilford CH; MacKenzie RD; Blohm TR; Grisar JM
    J Med Chem; 1973 Jun; 16(6):688-93. PubMed ID: 4715003
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of benzamidine derivatives on human platelet function.
    Glusa E; Barthel W; Markwardt F
    Thromb Diath Haemorrh; 1974 Mar; 31(1):172-8. PubMed ID: 4365541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.